•  
  •  
SlideBar

Projects

  • 1 A collaborative, multicentre, national trial for newly diagnosed patients with acute lymphoblastic leukaemia (ICiCLe-2014). Project no .1312; Principal Investigators- Dr B Arora & Dr. SD Banavali , CI-Dr Gaurav Narula
  • 2 A prospective study to investigate the impact of malnutrition on the pharmacokinetics of anticancer drugs in young children. Project no .1282; Principal Investigator- Dr PA Kurkure. CI-Dr B Arora & DR Gaurav Narula
  • 3 linical Presentation and outcome of Hodgkins disease in children : A retrospective study. Project no .1107; Principal Investigator- Dr B Arora, CI- Dr. SD Banavali, DR Gaurav Narula
  • 4 A prospective observational study to assess the side effects of Imatinib in pediatric patients with chronic myeloid leukemia. Project no .1278; Principal Investigator- Dr B Arora, CI- Dr. SD Banavali, DR Gaurav Narula
  • 5 LCH IV- IVth International study treatment protocol for patients of Langerhans cells Histiocytosis. Project no .1158; Principal Investigator- Dr G Narula, CI – Dr B Arora & Dr. SD Banavali
  • 6 Baseline high resolution CT scan thorax for detecting respiratory infection in patients with acute myeloid leukemia at presentation.Project no .1170; Principal Investigator- Dr  SD Banavali, CI-B Arora & Dr G Narula
  • 7 A retrospective analysis of clinical characteristics, treatment and outcome of children with T-cell Non-Hodgkins lymphoma treated at Tata Memorial Centre from 2003-2009. Project no .961; Principal Investigator- Dr  SD Banavali, CI-B Arora
  • 8 Retrospective Analysis Of  Vitamin D Levels In Patients With Malignancies Attending Paediatric Outpatient Department At Tata Memorial Centre. Project no .966. Principal Investigator- Dr  SD Banavali, CI-B Arora
  • 9 A prospective randomized, open-labeled parallel group trial of L- asparaginase vs. Prednisolone  in a subset of  newly diagnosed patients in  acute lymphoblastic leukemia  presenting with hyperleukocytosis. Project no .885. Principal Investigator- Dr  SD Banavali, CI-B Arora
  • 10 Risk Factors, Clinical course and outcome of Chemotherapy induced Febrile Neutropenia in children: a retrospective study. Project no .953 Principal Investigator- Dr  SD Banavali, CI-B Arora
  • 11Validation of BCR-ABL transcript level using ABL as a reference gene by Q- RT-PCR and establishing the conversion factor on an international reporting scale. Project no .853. Principal Investigator- A Chougle, CI- Dr  SD Banavali
  • 12 Clinical characteristics and outcome of children with acute myeloid leukemia treated at Tata Memorial Centre over past six years : A Retrospective analysis. Project no .826 Principal Investigator- Dr  SD Banavali, CI-B Arora
  • 13 A retrospective analysis of clinical characteristics, treatment and outcome of children with Anaplastic Large Cell Lymphoma treated at Tata Memorial Centre from 1997-2011.

    Project no .1312; Principal Investigator- Dr. SD Banavali & B Arora

  • 14 Two Vs Four Cycles Of ABVD Chemotherapy And Low Dose Radiation Therapy In Early Stage Favorable Prognosis Hodgkin's Disease : A Randomized Clinical Trial  Project No: 110; PI – Dr. Maryann Muckaden & Dr. S Laskar
  • 15 Molecular mechanisms underlying directional migration and retention of B-Cells within stromal microenvironment in Non-Hodgkin’s lymphoma: Role of SDF1/CXCR4 Signaling Axis” Project No: 317; PI – Dr. Jyoti Kode
  • 16 Burkitt like lymphomas- in search of morphologic, clinical and immune- phenotypic characteristics. Project No : 446; PI – Dr. Tanuja Shet
  • 17 A phase II single arm prospective study evaluating a novel regimen in the treatment of advanced Hodgkin’s Lymphoma: ABVD-P: addition of prednisolone to ABVD. Project No: 460; PI – Dr. Sudeep Gupta
  • 18 Comparison of Immune response pattern in nodular lymphocyte predominant Hodgkin lymphoma and T cell/histiocyte rich B cell lymphoma. Project No : 644; PI – Dr. Tanuja Shet
  • 19 “Minimal residual disease studies in Acute Lymphoblastic Leukemias by flow cytometer." Project no.472;  PI- P.G.Subramanian & Dr. S D Banavali
  • 20 The treatment and characterization of Acute Lymphoblastic Leukemia in Children, Adolescents and Young Adults: INCTR 02 04. Project no .121; Principal Investigator- Dr. SD Banavali
  • 21 Comparative Analysis of gene expression profiles of TCR γδ+ VS TCR αβ+ T     Acute Lymphoblastic Leukemia. Project no. 268, Principal Investigator- Dr. Chiplunkar SV & Dr. SD Banavali
  • 22 A randomized Comparative trial evaluating the safety and efficacy of Liposomal Amphotericin (Fungisome) versus conventional AmphotericinB in empirical treatment of Febrile Neutropenia. Project no.257 Principal Investigator-Dr. Kurkure PA.
  • 23 Evaluation of Low cost protocol for treatment of acute lymphoblatic leukemia in Indian children. Project no. 379. Principal Investigators- Dr. Kurkure PA &  Dr Arora Brijesh.
  • 24 A randomized open labeled parallel group phase III study of antibiotics alone versus antibiotics plus granulocyte-colony-stimulating factor in pediatric patients with chemotherapy induced febrile neutropenia in a developing country. Project no. 380. Principal Investigator- Dr. Arora Brijesh
  • 25 To Evaluate the Pharmacokinetics of Imatinib in Indian Patients of Chronic Myeloid Leukemia and the Possible Role of Therapeutic Drug Monitoring. Project no. 622. Principal Investigator- Dr. Arora Brijesh
  • 26 Study of Nutritional Assessment and Quality of Life in Children Receiving Radiation Therapy. Project no. 531; Principal Investigator- Dr. Siddharth Laskar
  • 27 Is current dosing recommendation of voriconazole appropriate for Indian pediatric patients? A dose – concentration – efficacy study . Project No 669; Principal Investigator- Dr. Gota Vikram. Co-Principal Investigator- Arora Brijesh
  • 28 A randomized open labeled parallel group phase III study of low-dose versus standard dose granulocyte colony stimulating factor prophylaxis in Paediatric cancer patients receiving chemotherapy. Project No 669; Principal Investigator-  Arora Brijesh
  • 29 To study the expression levels of class I &II Histone deacetylase (HDAC) genes before and after in-vitro treatment with Valproic acid (VPA) in patients with newly diagnosed, relapsed and refractory acute myeloid leukemia (AML)  Project no. no-503. Principal Investigator-  Chougle A & Dr SD Banavali
  • 30 IAEA CRP on optimisation of radiotherapy in low resource settings for Paediatric Cancer patients (2008-2012) Project no. 794; Principal Investigator: Dr. Sidharth Laskar.
  • 31 Evaluation of stem cells in testicular biopsies of young adult survivors of childhood cancer. Project no 789; Principal Investigator : Dr.Purna Kurkure
  • 32 Role of plasma BNP (Brain, natriuretic peptide) levels as a screening test for anthracycline induced cardiotoxicity:a pilot study. Project no 483; Principal Investigators : Dr.Aruna Alahari &  Dr.Purna Kurkure
  • 33 A Phase IIb, Partially-Blinded, Randomized, Active Comparator-Controlled Study to Evaluate the Pharmacokinetics/Pharmacodynamics, Safety, and Tolerability of Fosaprepitant in Pediatric Patients for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) Associated with Emetogenic Chemotherapy”  Project.no. 1238; Principal Investigator- Dr  SD Banavali, CI-B Arora & Dr G Narula 

Contact Us

TATA MEMORIAL HOSPITAL
Dr. E Borges Road, Parel, Mumbai - 400 012 India
Phone: +91-22- 24177000, 24177300, 24161413
Fax: +91-22-24146937
E-mail : msoffice@tmc.gov.in(for patient care and queries)/cash@tmc.gov.in(for accounts related)/fundraising@tmc.gov.in (for donors and donation related)/registrar@tmc.gov.in(for education and training)/hrd@tmc.gov.in(for administrative - HRD matters) This email address is being protected from spambots. You need JavaScript enabled to view it.

1152238 (382)